On November 6, 2024, Patrick Carroll, the Chief Medical Officer of Hims & Hers Health Inc (HIMS, Financial), executed a sale of 15,000 shares of the company. The transaction was filed with the SEC and can be viewed in detail through the SEC Filing. Following this sale, the insider now owns 196,941 shares of Hims & Hers Health Inc.
Hims & Hers Health Inc, a telehealth company that provides modern personalized health and wellness experiences to consumers, has been active in the stock market with a current market cap of approximately $4.91 billion. The company's shares were trading at $22.07 on the day of the transaction.
Over the past year, Patrick Carroll has sold a total of 45,000 shares and has not made any purchases. The broader insider transaction trend at Hims & Hers Health Inc shows a predominance of selling activities, with 93 insider sells and only 1 insider buy over the last year.
The company's current price-earnings ratio stands at 51.11, which is above the industry median of 18.16. This ratio suggests a higher valuation compared to the industry average.
According to the GF Value, the intrinsic value of Hims & Hers Health Inc's stock is estimated at $16.45, making the current price of $22.07 significantly overvalued with a price-to-GF-Value ratio of 1.34.
The GF Value is calculated based on historical trading multiples such as the price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, adjusted for the company's past performance and expected future business outcomes.
This sale by the insider may be of interest to current and potential investors, providing insight into the insider's perspective on the stock's current valuation and future prospects.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
